Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Journal of Internal Medicine Concepts & Practice    2021, 16 (03): 220-224.   DOI: 10.16138/j.1673-6087.2021.03.018
    Abstract1097)   HTML13)    PDF(pc) (531KB)(13291)       Save
    Reference | Related Articles | Metrics | Comments0
    Expert consensus on multidisciplinary diagnosis and treatment of primary Sjögren syndrome (2024 edition)
    CHENG Fang, ZHAO Futao, SHEN Xuemin, LI Jin, CHEN Xiangjun, WANG Guifang, LI Huilin, XUE Luan, QI Junyuan
    Journal of Internal Medicine Concepts & Practice    2024, 19 (06): 357-362.   DOI: 10.16138/j.1673-6087.2024.06.01
    Abstract1588)   HTML67)    PDF(pc) (923KB)(4081)       Save

    Primary Sjögren syndrome (PSS) is an autoimmune disease characterized by lymphocytic infiltration of exocrine glands and other organs. PSS shows strong clinical heterogeneity, presents different degrees of topical and systemic damage, and multidisciplinary collaboration are required to develop PSS treatment strategies. However, our country currently has not unified diagnosis and treatment consensus for PSS. Based on domestic and foreign diagnosis and treatment experience, consensus and guideline, experts from multiple related disciplines achieved consensus using the nominal group technique, providing guidance and reference for standardized diagnosis and treatment of PSS.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2022, 17 (03): 262-266.   DOI: 10.16138/j.1673-6087.2022.03.018
    Abstract992)   HTML20)    PDF(pc) (477KB)(3889)       Save
    Reference | Related Articles | Metrics | Comments0
    Value of serum N-terminal pro-brain natriuretic peptide levels in primary screening peritoneal dialysis patients with volume overload
    LI Hua, HUANG Xiaomin, ZHANG Chunyan, DU Lu, REN Hong, XU Tian
    Journal of Internal Medicine Concepts & Practice    2023, 18 (03): 157-164.   DOI: 10.16138/j.1673-6087.2023.03.005
    Abstract1063)   HTML1)    PDF(pc) (845KB)(3704)       Save

    Objective To explore the relationship between serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level and hydration status and cardiac function indexes in the patients receiving peritoneal dialysis(PD) treatment,and to further analyze the factors affecting the level of NT-proBNP. Methods A total of 111 patients with PD who were followed up in the PD Center of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from May 2019 to January 2022 were enrolled and the data was analyzed retrospectively. According to the results of multi-frequency bioelectrical impedance body composition monitor (BCM), relative hydration status (DHS), the ratio obtained through dividing extracellular water (ECW) by overhydration (OH), the patients were divided into normal volume group (OH/ECW≤15%) and overhydration group (OH/ECW>15%). The relationship between serum NT-proBNP level and hydration status in two groups was compared, and the related factors affecting the level of NT-proBNP were further analyzed and discussed. Using BCM result as the“gold standard”, the receiver operator characteristic curve(ROC curve) determined the optimal threshold of NT-proBNP as the capacity was overloaded. The patients were divided into two groups according to NT-proBNP and their clinical data were compared. Results The indexes including systolic blood pressure, urine volume, urea clearance index (Kt/V), creatinine clearance rate(CCr), dialysate to plasma ratio for urea at 4 hours(4hD/PCr), types of antihypertensive drugs, type of diuretic, hemoglobin, serum albumin, log2(NT-proBNP), interventricular septal thickness (IVST), left ventricular posterior wall thickness(LVPWT), left atrial diameter(LAD), OH, TBW, ECW, OH/TBW, ECW/TBW and ECW/ICW were detected in volume overload group and normal volume group, and showed statistically significant (all P<0.05). log2(NT-proBNP) level was correlated with systolic blood pressure, dialysis duration, ultrafiltration volume, dialysis dose, antihypertensive drug group, IVST, LVPWT, LAD, left ventricular end-systolic dimension (LVESD), left ventricular end-diastolic dimension (LVEDD), OH, OH/ECW were positively correlated (all P<0.05). It was negatively correlated with urine volume, Kt/V, CCr, normalized protein catabolic rate (nPCR), hemoglobin, serum albumin and LVEF (all P<0.05). NT-proBNP 4 896 ng/L could be used as the critical value of initial screening capacity overload and was applied to divide the patients into two groups, and the systolic blood pressure, urine volume, ultrafiltration volume, Kt/V, CCr, IVST, LVPWT, OH/ECW indicators showed significant differences (all P<0.05) in two groups. Conclusions The level of NT-proBNP in PD patients is generally increased, and it indicates volume overload as its value is greater than 4 896 ng/L, which can be used as a simple monitoring index for the preliminary judgment of volume overload in PD patients.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2022, 17 (04): 344-348.   DOI: 10.16138/j.1673-6087.2022.04.015
    Abstract1250)   HTML20)    PDF(pc) (526KB)(3535)       Save
    Reference | Related Articles | Metrics | Comments0
    Reliability and validity of the ultra-brief screening scale for depression and anxiety in outpatients clinics of community healthcare centers
    QIAN Jie, JIANG Minmin, CHEN Chen, CHEN Yujiao, YU Dehua, LI Chunbo
    Journal of Internal Medicine Concepts & Practice    2021, 16 (02): 116-120.   DOI: 10.16138/j.1673-6087.2021.02.010
    Abstract1910)   HTML66)    PDF(pc) (516KB)(2877)       Save

    Objective To preliminary evaluate the reliability and validity of the ultra-brief screening scale for depression and anxiety [patient health questionnaire 4 (PHQ-4)] in outpatients clinics of community healthcare centers. Methods Totally 313 patients were randomly selected from two community healthcare centers in Shanghai. The patients were asked to complete the PHQ-4 following the prescribed instruction with assistance of a psychiatrist and two physicians, and then were evaluated according Hamilton depression scale(HAMD) and the Hamilton anxiety scale(HAMA) followed by a mini international neuropsychiatric interview(MINI). Out of subjects screened, 50 patients were randomly selected to retest the PHQ-4. The reliability coefficients, retest reliability and criterion validity sensitivity and specificity were calculated. The receiver operating characteristic(ROC) analysis was performed to determine the best cut-off value, and the sensitivity and specificity accordingly. Results The Cronbach’α coefficient of PHQ-4 was 0.833, the Spearman-Brown coefficient of the split-half reliability was 0.835. For the test-retest reliability, the intraclass correlation coefficient (ICC) was 0.969. The correlation coefficients of generalized anxiety disorder 7(GAD-7) with HAMD and HAMA were 0.391 and 0.407 respectively, both statistically significant (P<0.01). ROC analysis showed that the area under curve(AUC) was 0.919, and the best cut-off value was 3, the sensitivity and specificity of PHQ-4 were 87.1% and 82.6% respectively. Conclusions The Chinese version of the PHQ-4 maintains high reliability and validity in outpatient clinics of community healthcare centers, and is suitable for the screening of depression and anxiety.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2022, 17 (03): 267-272.   DOI: 10.16138/j.1673-6087.2022.03.019
    Abstract1096)   HTML16)    PDF(pc) (549KB)(2854)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2022, 17 (03): 258-261.   DOI: 10.16138/j.1673-6087.2022.03.017
    Abstract1256)   HTML59)    PDF(pc) (363KB)(2762)       Save
    Reference | Related Articles | Metrics | Comments0
    Research progress of Hashimoto thyroiditis
    TIAN Limin, FENG Jing
    Journal of Internal Medicine Concepts & Practice    2024, 19 (04): 217-223.   DOI: 10.16138/j.1673-6087.2024.04.01
    Abstract2896)   HTML82)    PDF(pc) (973KB)(2760)       Save

    Hashimoto thyroiditis (HT) is a very common organic autoimmune thyroid disease, and its incidence is increasing year by year. It not only causes hypothyroidism in clinical practice, but also has many connections with a variety of immune diseases, endocrine diseases, rheumatic diseases and thyroid cancer. Although the exact etiology of HT has not been fully clarified, the mainstream treatment is still based on management and alternative treatment of hypothyroidism. However, as the research further deepens, more clinical variants have been gradually discovered, more and more factors have been found to be related to the onset of HT, and new discoveries have been made in treatment methods. This article reviews the research progress on clinical manifestations, pathological features, diagnosis, pathogenesis, relationship with other diseases and treatment of HT.

    Reference | Related Articles | Metrics | Comments0
    Advances in human respiratory microbiome and detection techniques
    WU Wenjuan, TIAN Wenjie
    Journal of Internal Medicine Concepts & Practice    2024, 19 (01): 37-42.   DOI: 10.16138/j.1673-6087.2024.01.07
    Abstract657)   HTML10)    PDF(pc) (909KB)(2744)       Save

    Human respiratory microbiome has great diversity and heterogeneity in healthy and diseased states, rapid and accurate microbial detection is the key to distinguish respiratory tract infection from non-infection. In recent years, new detection technologies represented by metagenomic technology have developed rapidly in the field of pathogen diagnosis, which improves the detection rate of pathogenic microorganisms, and also makes great breakthroughs in analyzing human host reaction and predicting drug resistance. This article reviews the research progress and achievements of molecular technology in the respiratory microbiome, inspiring readers to think about the development and clinical transformation of new technologies in the future, aiming to explore therapeutic strategies for respiratory diseases based on the respiratory microbiome.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    COVID-19 vaccine induced thyroid disease: challenges and strategies
    YUAN Li, XIANG Pingping, CHEN Guofang, et al
    Journal of Internal Medicine Concepts & Practice    2023, 18 (02): 121-123.   DOI: 10.16138/j.1673-6087.2023.02.012
    Abstract1014)   HTML43)    PDF(pc) (310KB)(2552)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progress in treatment of adult acute lymphoblastic leukemia
    LIU Wenhui, WU Tao, ZHANG Xi
    Journal of Internal Medicine Concepts & Practice    2024, 19 (03): 201-206.   DOI: 10.16138/j.1673-6087.2024.03.10
    Abstract892)   HTML23)    PDF(pc) (917KB)(2499)       Save

    Acute lymphoblastic leukemia (ALL) is a hematological malignancy with abnormal proliferation of primitive naive lymphocytes and inhibition of normal hematopoiesis. It originates from B-lineage or T-lineage lymphoid progenitor cells, accounting for 20%-30% of adult acute leukemia. Although the complete remission rate of newly diagnosed adult ALL patients after multi-drug combination chemotherapy can reach more than 80%, most of the patients still show relapse and refractory. The 5-year long term survival rate in the patients is only 20%-40% and the clinical characteristics and prognosis are quite different. In recent years, with the advent of targeted drugs, immunotherapy, and chimeric antigen receptor (CAR) -T cell therapy, the clinical outcomes of adult ALL patients have been greatly improved. This article reviews the current progress of new therapeutic drugs for adult ALL in detail.

    Reference | Related Articles | Metrics | Comments0
    Progress in treatment of activated phosphoinositide 3-kinase δ syndrome
    WU Tao, LIU Wenhui
    Journal of Internal Medicine Concepts & Practice    2024, 19 (02): 140-143.   DOI: 10.16138/j.1673-6087.2024.02.10
    Abstract666)   HTML6)    PDF(pc) (904KB)(2473)       Save

    Phosphoinositide 3-kinase δ (PI3Kδ) activated phosphoinositide 3-kinase δ syndrome (APDS) was first reported in 2013. APDS is an autosomal dominant primary immunodeficiency disease (PID) caused by mutations in the PIK3CD gene or PIK3R1 gene. The clinical manifestations of APDS are recurrent respiratory tract infection, non-neoplastic lymphoid hyperplasia, autoimmune diseases and lymphoma. In this paper, the treatment of APDS is introduced in detail. In addition to conventional treatment for immunodeficiency, treatment such as antimicrobial prophylaxis, immunoglobulin replacement therapy and hematopoietic stem cell transplantation were reviewed, and more specific mammalian target of rapamycin (mTOR) inhibitors and PI3Kδ inhibitors were also discussed.

    Reference | Related Articles | Metrics | Comments0
    Novel coronavirus infection: a new challenge for the management of thyroid disease
    XIANG Pingping, LIU Chao
    Journal of Internal Medicine Concepts & Practice    2022, 17 (06): 486-490.   DOI: 10.16138/j.1673-6087.2022.06.013
    Abstract633)   HTML2)    PDF(pc) (531KB)(2436)       Save
    Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2022, 17 (03): 202-207.   DOI: 10.16138/j.1673-6087.2022.03.006
    Abstract875)   HTML7)    PDF(pc) (711KB)(2350)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progress of research on Niemann-Pick disease type A and type B
    QIAN Lan, WU Tao
    Journal of Internal Medicine Concepts & Practice    2022, 17 (06): 471-474.   DOI: 10.16138/j.1673-6087.2022.06.010
    Abstract517)   HTML0)    PDF(pc) (467KB)(2249)       Save
    Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2021, 16 (01): 53-59.   DOI: 10.16138/j.1673-6087.2021.01.012
    Abstract1009)   HTML24)    PDF(pc) (774KB)(2239)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Therapeutic effect of theta burst transcranial magnetic stimulation combined with speech training on aphasia after stroke
    ZENG Zhen, LU Chunhua, WANG Kai, ZHANG Qin
    Journal of Internal Medicine Concepts & Practice    2024, 19 (04): 231-235.   DOI: 10.16138/j.1673-6087.2024.04.03
    Abstract547)   HTML4)    PDF(pc) (3195KB)(2224)       Save

    Objective Analyzing the clinical treatment efficacy of continuous theta burst stimulation (cTBS), theta burst stimulation (TBS) combined with speech training on post stroke aphasia (PSA). Methods In this study, 90 PSA patients admitted to our hospital from February 2022 to January 2023 were divided into three groups according to different treatment methods, each 30 cases in each group. The basic group was given speech training, the observation group 1 was given cTBS combined speech training, and the observation group 2 was given iTBS combined speech training. The clinical efficacy, western aphasia battery (WAB) score, view naming test results, Boston diagnostic aphasia examination (BDAE) rating, stroke aphasia quality of life scale (SAQOL-39g) score were compared among the three groups. Results The total clinical effective rate (96.67%, 93.33%) in observation group 1 and observation group 2 were higher than that in basic group (60.00%) (P<0.05). After treatment, WAB score and correct number of view naming test in observation group 1 and observation group 2 were higher than those in basic group (P<0.05). The reaction time of view naming test in observation group 1 and observation group 2 were shorter than that in basic group (P<0.05). The improvement degree of BDAE grade in observation group 1 and observation group 2 after treatment were better than that in basic group (P<0.05). The SAQOL-39g score in observation group 1 and observation group 2 after treatment was higher than that in basic group (P<0.05). The total clinical response rate, WAB score after treatment, correct number of view naming tests, response time, improvement effect of BDAE classification, and SAQOL-39g score didn’t show significant difference between observation group 1 and group 2 (P>0.05). Conclusions Both cTBS and iTBS combined speech training can improve aphasia symptoms, view naming ability and quality of life in PSA patients. The clinical efficacy of them is comparable, and both are better than single speech training.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Internal Medicine Concepts & Practice    2021, 16 (03): 145-150.   DOI: 10.16138/j.1673-6087.2021.03.002
    Abstract636)   HTML13)    PDF(pc) (622KB)(2188)       Save
    Reference | Related Articles | Metrics | Comments0
    Development of preliminary scales for elderly sarcopenia based on Delphi method
    LI Feika, YANG Wenli, JIANG Qianwen, FANG Fang, BAI Tingting, XU Gang, WU Fang, HE Qing
    Journal of Internal Medicine Concepts & Practice    2022, 17 (03): 238-242.   DOI: 10.16138/j.1673-6087.2022.03.012
    Abstract1109)   HTML16)    PDF(pc) (521KB)(2150)       Save

    Objective To develop the preliminary scales suitable to the comprehensive assessment scale for elderly sarcopenia in China (including self-evaluation and evaluation from others). Methods Through searching and reviewing literatures, the scales related to sarcopenia were selected and a preliminary item pool was formed. The items were screened through two rounds of Delphi consultation questionnaires completed by 16 domestic experts in related fields. Through analyzing the expert positive coefficient, expert authority level, coordination coefficient of the importance of expert opinions, average value of each index score, coefficient of variation and the full score rate, the preliminary scales for evaluating sarcopenia in the elderly were developed. Results After literature collection and expert discussion, the initial item pools of self-assessment (3 first-level items, 5 second-level items, 21 third-level items) and assessment from others (2 first-level items, 4 second-level items and 17 third-level items) were developed. The expert positive coefficient in the first round of Delphi consultation was 100%, and the coefficient of expert authority was Cr=0.956. In the self-evaluation and evaluation from others, the Kendall coordination coefficients of the importance of experts to all items were 0.424 and 0.449, and χ2 were 133.534 (P<0.001) and 114.591 (P<0.001), respectively. The positive coefficient of expert in second round of Delphi consultation was 100%, and the authority coefficient of expert was Cr=0.968. In self-evaluation and evaluation from others, the Kendall coordination coefficients of the importance of experts to all items were 0.350 and 0.400, and χ2 are 84.119 (P<0.001) and 67.546 (P<0.001), respectively. According to two rounds scores of Delphi consultation and the expert opinions of modification, the item pools of self-assessment (3 first-level items, 5 second-level items and 10 third-level items) and assessment from others(2 first-level items, 4 second-level items and 13 three-level items) were finally formed. Conclusions The preliminary scales for comprehensive assessment of elderly sarcopenia developed through Delphi expert consultation method involved active participation of experts, and presented high level of expert authority, and well concentrated and coordinated opinions from experts.

    Table and Figures | Reference | Related Articles | Metrics | Comments0